Showing results (51-60 of 187) with videos related to
Sort By:
Pageof 19
Pharmacogenetics and Genomics|June 3, 2011
Genetic risk factors for type 2 diabetes mellitus and response to sulfonylurea treatmentJesse J Swen, Henk-Jan Guchelaar, Renée F Baak-Pablo, et al.Journal of Clinical Medicine|March 21, 2020
Assessing the Implementation of Pharmacogenomic Panel-Testing in Primary Care in the Netherlands Utilizing a Theoretical FrameworkCathelijne H van der Wouden, Ellen Paasman, Martina Teichert, et al.European Journal of Human Genetics : EJHG|June 23, 2019
A pilot study of the implementation of pharmacogenomic pharmacist initiated pre-emptive testing in primary carePaul C D Bank, Jesse J Swen, Rowena D Schaap, et al.Pharmacogenomics|June 23, 2017
Pathway analysis to identify genetic variants associated with efficacy of adalimumab in rheumatoid arthritisFrank Eektimmerman, Jesse J Swen, Stefan Böhringer, et al.Tijdschrift Voor Gerontologie En Geriatrie|December 15, 2010
[Reversible cognitive decline in a patient with relapsing polychondritis]S J Swen, D J H Leonards, W A A Swen, et al.Drug Discovery Today|April 22, 2014
Personalized busulfan and treosulfan conditioning for pediatric stem cell transplantation: the role of pharmacogenetics and pharmacokineticsM H ten Brink, J Zwaveling, J J Swen, et al.British Journal of Clinical Pharmacology|November 5, 2023
Implementation of pre-emptive testing of a pharmacogenomic panel in clinical practice: Where do we stand?Elena Peruzzi, Rossana Roncato, Elena De Mattia, et al.Pharmacogenomics|July 27, 2017
The effect of rs5758550 on CYP2D6*2 phenotype and formation of endoxifen in breast cancer patients using tamoxifenAnabel B Sanchez-Spitman, Dirk-Jan Ar Moes, Hans Gelderblom, et al.European Journal of Clinical Pharmacology|August 30, 2017
Effect of CYP3A4*22, CYP3A5*3, and CYP3A combined genotypes on tamoxifen metabolismA B Sanchez Spitman, D J A R Moes, H Gelderblom, et al.Scientific Reports|January 12, 2021
Effect of CYP2C19 genotypes on tamoxifen metabolism and early-breast cancer relapseA B Sanchez-Spitman, J J Swen, V O Dezentjé, et al.Pageof 19